Mental Health Clinics in Saint Albans, WV Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Tri County Behavioral Health, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 2215 Bellwood Dr, Saint Albans, WV 25177 Phone: 304-727-2010 |
Mareda L. Reynolds Ma Pllc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 200 Kanawha Ter, Suite 103, Saint Albans, WV 25177 Phone: 304-727-1302 Fax: 304-727-1302 |
Links Llc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 808 B St, Saint Albans, WV 25177 Phone: 681-265-9047 |
Red Barn Stables Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 7095 Smith Creek Rd, Saint Albans, WV 25177 Phone: 304-549-0561 |
Psyscape Pllc Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 201 6th Ave, Saint Albans, WV 25177 Phone: 304-552-9832 Fax: 866-212-0708 |
Anchor Project Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2333 Maccorkle Ave Ste 201, Saint Albans, WV 25177 Phone: 304-419-7252 Fax: 855-888-9316 |
News Archive
Obesity can be risk factor for developing renal cell carcinoma, confirms study
A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma, a type of kidney cancer, and identifies several specific obesity-related factors.
During the congressional break, voters air their frustrations
At a time of high unemployment and home foreclosure rates, frustration with Congress and rising anxiety over how to deal with the national debt without gutting programs such as Medicare health insurance for the elderly and the Social Security retirement program, such meetings aren't always comfortable for lawmakers.
U.S. District Court rules in favor of Allergan in its patent infringement suit against Exela PharmSci
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.
Inadequate information encoding linked to poor language ability
Study findings suggest that the impaired ability to retain and repeat unfamiliar phoneme sequences in children with specific language impairment reflects inadequate encoding of phonologic information, rather than problems retaining encoded information.
ACA offers simple walking tips to improve cardiovascular and muscle health
Sedentary lifestyles are the root cause of many obesity-related diseases and neuromuscular conditions. Research shows an inactive lifestyle has a debilitating effect on our cardiovascular and muscle health as we age, therefore exercise is imperative. This is why chiropractic physicians often advise walking more to help relieve low back pain and boost overall wellness.
› Verified 1 days ago